|
[ About the Section
| Responsibilities | Key Personnel |
Quality Assurance | Key Instruments
| Targets
and Key Indicators ]
[ Previous | Next
]
Pharmaceutical Quality and Investigation Section
About the
Section
|
The Section was established on 3 May 2010 under the Other Scientific Service Group of Analytical and Advisory Division. Its major activities are to perform safety evaluation of pharmaceutical items, including proprietary Chinese medicines, on sale in the market for western medicines adulteration and coordinate urgent services to the Department of Health for drug’s related incidents. |
Responsibilities
The Section will centralize all routine analytical works related to western medicines adulteration of proprietary Chinese medicines and other proprietary herbal medicines. The Section will also provide necessary analytical, investigatory and enforcement support to the Department of Health (DH) for urgent suspected poisoning cases concerning the consumption of products containing undeclared western drug ingredients. The Senior Chemist of the Section with the support from the Chemists of the Section will be the first contact point for drug’s related emergency incidents.
Key Personnel
Senior Chemist : Dr. P C Ng (Acting)
(Tel.
No.: 2319-8399 E-mail : pcng@govtlab.gov.hk)
Quality
Assurance
About 10% of the tests conducted in the Section
are for QC purposes.
Key
Instruments
|
The following instruments are used routinely
by the Section:
- High Performance Liquid Chromatograph - Ion Trap Mass spectrometer
- High Performance Liquid Chromatograph - Tandem Mass Spectrometer
|
Targets
and Key Indicators
Working closely with the Chinese Medicines Section and the Pharmaceutical Chemistry Section, the Key Performance Measures Relating to the Statutory Testing of Chinese Medicines and Pharmaceuticals are:
Targets
| Testing of Chinese Medicines |
Targets |
2009
(Actual) |
2010
(Actual) |
2011
(Plan) |
| Chinese Medicines within reporting time averaging 30 working days (%) * |
95 |
99 |
98 |
95 |
| Pharmaceuticals (quality control) within reporting time averaging 14 working days (%) * |
95 |
97 |
99 |
95 |
|
| * |
Different samples require different analytical procedures, thus different reporting time applies. The quoted number of working days required represents an average of reporting time for the different types of samples / test requests within the category, while the target (in percentage) is the total compliance rate of the concerned samples / test requests within a particular category against their respective targets. |
Key Indicators
Key Indicators for Statutory Testing of Chinese
Medicines
| Tests Performed on Chinese
Medicines |
2009
(Actual) |
2010
(Actual) |
2011
(Estimate) |
| Chinese Medicines |
68,864 |
95,890 |
78,800 |
| Pharmaceuticals (quality control) |
25,728 |
24,378 |
31,000 |
|
|
